scholarly article | Q13442814 |
P50 | author | Fotios Loupakis | Q46107172 |
Sara Lonardi | Q50876272 | ||
Nicola Valeri | Q56704921 | ||
Chiara Braconi | Q56704924 | ||
Salvatore Pucciarelli | Q56826838 | ||
Edoardo D'Angelo | Q57337633 | ||
Massimo Rugge | Q89598250 | ||
Fabio Farinati | Q90611754 | ||
Claudia Mescoli | Q114434042 | ||
Caterina Vicentini | Q114434065 | ||
Giada Munari | Q114434070 | ||
Matteo Fassan | Q39364695 | ||
Marco Scarpa | Q42722479 | ||
Ri Cui | Q42832482 | ||
Marco Agostini | Q43108192 | ||
P2093 | author name string | Vincenza Guzzardo | |
Pierluigi Gasparini | |||
Carlo Maria Croce | |||
Giovanni Lanza | |||
Roberta Gafà | |||
Wendy L Frankel | |||
Imerio Angriman | |||
Renata D'Incá | |||
P2860 | cites work | PDCD4/miR-21 dysregulation in inflammatory bowel disease-associated carcinogenesis | Q43827753 |
microRNA-224 promotes cell proliferation and tumor growth in human colorectal cancer by repressing PHLPP1 and PHLPP2. | Q44847765 | ||
The miR-224 promotes non-small cell lung cancer cell proliferation by directly targeting RASSF8. | Q47813275 | ||
Immunohistochemical evaluation of mismatch repair proteins in colorectal carcinoma: the AIFEG/GIPAD proposal | Q48696755 | ||
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer | Q49887005 | ||
miR-224 overexpression is a strong and independent prognosticator of short-term relapse and poor overall survival in colorectal adenocarcinoma. | Q50445432 | ||
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study. | Q50876217 | ||
The molecular landscape of colitis-associated carcinogenesis. | Q51190142 | ||
miR-224 enhances invasion and metastasis by targeting HOXD10 in non-small cell lung cancer cells. | Q55380508 | ||
MiR-21 up-regulation in ampullary adenocarcinoma and its pre-invasive lesions | Q57118576 | ||
Caspase-3 activity as a prognostic factor in colorectal carcinoma | Q73877869 | ||
MicroRNAs in cancer | Q86065522 | ||
Comprehensive molecular characterization of human colon and rectal cancer | Q24630415 | ||
Decreased levels of miR-224 and the passenger strand of miR-221 increase MBD2, suppressing maspin and promoting colorectal tumor growth and metastasis in mice | Q28118790 | ||
Downregulated USP3 mRNA functions as a competitive endogenous RNA of SMAD4 by sponging miR-224 and promotes metastasis in colorectal cancer | Q33842842 | ||
MicroRNA-224 targets SMAD family member 4 to promote cell proliferation and negatively influence patient survival | Q34901737 | ||
MicroRNA-224 is associated with colorectal cancer progression and response to 5-fluorouracil-based chemotherapy by KRAS-dependent and -independent mechanisms | Q35677921 | ||
MicroRNA-224 promotes tumor progression in nonsmall cell lung cancer | Q35946366 | ||
The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis | Q36090214 | ||
Over-Expressed miR-224 Promotes the Progression of Cervical Cancer via Targeting RASSF8 | Q36132470 | ||
The consensus molecular subtypes of colorectal cancer | Q36258187 | ||
MicroRNA-224 is implicated in lung cancer pathogenesis through targeting caspase-3 and caspase-7 | Q36355801 | ||
MicroRNA-224 sustains Wnt/β-catenin signaling and promotes aggressive phenotype of colorectal cancer | Q36517485 | ||
Up-regulation of miR-224 promotes cancer cell proliferation and invasion and predicts relapse of colorectal cancer | Q37320486 | ||
Hypoxia-inducible microRNA-224 promotes the cell growth, migration and invasion by directly targeting RASSF8 in gastric cancer | Q37631115 | ||
MicroRNA-135b promotes cancer progression by acting as a downstream effector of oncogenic pathways in colon cancer | Q37715770 | ||
MicroRNA-224 suppresses colorectal cancer cell migration by targeting Cdc42. | Q37731426 | ||
Chronic idiopathic inflammatory bowel diseases: the histology report. | Q37860670 | ||
Colorectal tumors: the histology report. | Q37860677 | ||
Advanced precancerous lesions within the GI tract: the molecular background. | Q38117755 | ||
MicroRNAs as tools and effectors for patient treatment in gastrointestinal carcinogenesis | Q38286304 | ||
PD-L1 overexpression in ampulla of Vater carcinoma and its pre-invasive lesions | Q38787346 | ||
Global patterns and trends in colorectal cancer incidence and mortality. | Q38915351 | ||
miR-224 promotion of cell migration and invasion by targeting Homeobox D 10 gene in human hepatocellular carcinoma | Q39064162 | ||
Fecal miR-29a and miR-224 as the noninvasive biomarkers for colorectal cancer. | Q40118222 | ||
miR-224 Controls Human Colorectal Cancer Cell Line HCT116 Proliferation by Targeting Smad4. | Q41035735 | ||
MicroRNA-224 negatively regulates p21 expression during late neoplastic progression in inflammatory bowel disease | Q41839952 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | carcinogenesis | Q1637543 |
P304 | page(s) | 282-291 | |
P577 | publication date | 2018-11-16 | |
P1433 | published in | Translational Oncology | Q26839583 |
P1476 | title | miR-224 Is Significantly Upregulated and Targets Caspase-3 and Caspase-7 During Colorectal Carcinogenesis | |
P478 | volume | 12 |
Q64099930 | Mechanism of exosomal microRNA-224 in development of hepatocellular carcinoma and its diagnostic and prognostic value | cites work | P2860 |
Search more.